novopro labs retatrutide Novera 20mg Retatrutide (Reta GLP-3) - 99%+

It includes everything you do physically that is not structured exercise: walking, fidgeting, standing, cleaning, climbing stairs, carrying groceries

Retatrutide (GLP-1/GIP/glucagon receptor agonist) in type 2 diabetes: phase 2 trial. The Lancet

Introduction The inflammatory bowel diseases (IBDs), including Crohns disease (CD) and ulcerative colitis (UC), are chronic conditions characterized by a disrupted intestinal epithelial barrier and persistent and excessive gastrointestinal inflammation driven by a dysregulated immune response in a genetically susceptible host [1]

Adding another layer of complexity, a multinational survey revealed that only 26% of clinicians viewed obesity as a chronic disease, and fewer than half routinely recorded it as such in patients medical files (Dixon et al., 2025)

Gerstein HC, Hart R, Colhoun HM, Diaz R, Lakshmanan M, Botros FT, et al

Clinical studies show an average of 5-10% weight loss by month 3, with continued progress over time